Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

ARMP holding history

Armata Pharmaceuticals, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARMP overviewAll 13F holders of ARMPFull Q2 2026 holdings

Shares (Q2 2026)
4,583
Value
$29.7K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ARMP by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,583$29.7K<0.1%+1,216+36.1%AddedHolders
Q1 20263,367$34.5K<0.1%+1,098+48.4%AddedHolders
Q4 20252,269$14.3K<0.1%+2,267+113,350.0%AddedHolders
Q3 20252$6<0.1%−107−98.2%ReducedHolders
Q2 2025109$207<0.1%00.0%UnchangedHolders
Q1 2025109$159<0.1%00.0%UnchangedHolders
Q4 2024109$202<0.1%00.0%UnchangedHolders
Q3 2024109$258<0.1%+107+5,350.0%AddedHolders
Q2 20242$6<0.1%−424−99.5%ReducedHolders
Q1 2024426$1.78K<0.1%+424+21,200.0%AddedHolders
Q4 20232$6<0.1%00.0%UnchangedHolders
Q3 20232$6<0.1%00.0%UnchangedHolders
Q2 20232$2<0.1%00.0%UnchangedHolders
Q1 20232$3<0.1%−12−85.7%ReducedHolders
Q4 202214$17<0.1%+13+1,300.0%AddedHolders
Q3 20221$00.0%−1,070−99.9%ReducedHolders
Q2 20221,071$4.00K<0.1%00.0%UnchangedHolders
Q1 20221,071$5.00K<0.1%−14−1.3%ReducedHolders
Q4 20211,085$6.00K<0.1%−58−5.1%ReducedHolders
Q3 20211,143$4.00K<0.1%−849−42.6%ReducedHolders
Q2 20211,992$8.00K<0.1%00.0%UnchangedHolders
Q1 20211,992$10.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.